Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Paid advertising most likely but good PR nevertheless
View:
Post by itntdf on Dec 29, 2023 9:51am

Paid advertising most likely but good PR nevertheless

https://usanewsgroup.com/2023/10/02/the-most-undervalued-oncolytics-company-on-the-nasdaq/?utm_source=taboola&utm_medium=referral&tblci=GiC3MwJOWAb4b1pc7rv6ae9G0Nz5Xj7zpTCjVT52EOKk4yCelmIopIT16Juh-pYC#tblciGiC3MwJOWAb4b1pc7rv6ae9G0Nz5Xj7zpTCjVT52EOKk4yCelmIopIT16Juh-pYC
Comment by 13X2413 on Dec 29, 2023 11:18am
It looks like that was from September. Another bad analyst's prediction. I only wish it was more recent. 
Comment by Noteable on Dec 29, 2023 11:36am
Infomercial print pieces have demonstrated to be a bad strategy for this stock.
Comment by lonc17 on Dec 29, 2023 12:11pm
These paid for promotional "news" items should be a red-flag for any biotech investor.
Comment by itntdf on Dec 29, 2023 1:07pm
pancan made the oncolytics announcement around sept 26.  this article was "dated" december 29 but obviously did not make mention that pancan was cancelling further trials while they were doing a "strategic re-evaluation". can find no mention of ANY strategic reevaluation in any pancan links.  the only mention of a strategic reevaluation was in oncy's press ...more  
Comment by Noteable on Dec 29, 2023 2:02pm
Who cares about Andrew de Guttadauro. He accomplished absolutely nothing!
Comment by itntdf on Dec 29, 2023 3:48pm
the issue is not so much "caring" about guttadauro as it is why hasn't oncy made any filing or announcement about the status of the president of obus.   similar to wondering why when oncy had its conference call no mention was made about the pancan issue when they certainly knew about it.
Comment by canadafan on Dec 29, 2023 3:59pm
The PanCan issue was updated as a press release as soon as they knew.
Comment by lonc17 on Dec 29, 2023 4:03pm
ONC and MC are sinking to new lows (along with the share price) everyday. They have now taken to releasing paid for "news bait" phoney articles that contain misleading information (PANCAN in this case). No doubt Canadafanatic will jump in to immediately defend MC!
Comment by Azzak34 on Dec 29, 2023 4:10pm
He may say you've told lies in your last post. He may also say that the share price is not hitting new lows everyday. Posts like your last one are how we know your agenda Brenda.  What's your name on Stocktwits? 
Comment by lonc17 on Dec 29, 2023 4:15pm
Last twenty years I've always defended ONC when friends and family have suggested it is a bit of a bogus scam. I've always talked about the science and real trials they are running. Now that ONC has run its course and is without partner/buyout/funding prospects to conduct a phase three, I can no longer defend this company. ONC and MC are surely most interested in keeping the gravy ...more  
Comment by lonc17 on Dec 29, 2023 4:17pm
MC reminds me a lot of Brad Thompson in the year or so prior to his termination of employment.
Comment by Azzak34 on Dec 29, 2023 4:42pm
So if you don't have any shares why are you here?  What's your name on Stocktwits? 
Comment by itntdf on Dec 29, 2023 4:49pm
that explanation doesn't wash when the biggest thing on the early 2024 horizon for oncy failed to get even a mention in the conference call.   if oncy had no idea pancan was "backing out", it deserved some type of mention in the cc and if they did know then it also deserved some type of mention. oncy had been 4th and goal for years and it needs to be moved into the end ...more  
Comment by JohnnyYeg on Dec 29, 2023 5:52pm
I personally wouldn't say we've been 4 and goal for years. To me we have been 4 and 1 on the 21, always so close to the red zone. That said, I think finally, throughout 2023, we have penetrated the red zone and are 4th and goal with two and potentially three phase 3s that will reward us with the big game winning TD. How the Andrew dG situation plays out, it's anyone's guess. But ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities